L. R. Petersen, D. J. Jamieson, A. M. Powers, and M. A. Honein, Zika virus, N. Engl. J. Med, vol.374, pp.1552-1563, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01465099

S. A. Rasmussen, D. J. Jamieson, M. A. Honein, and L. R. Petersen, Zika virus and birth defects-reviewing the evidence for causality, N. Engl. J. Med, vol.374, pp.1981-1987, 2016.

, www.moleculartherapy.org Molecular Therapy, vol.28, issue.8, 2020.

, Countries and territories with current or previous Zika virus transmission, World Health Organization, 2019.

J. Moreira, T. M. Peixoto, A. M. Siqueira, and C. C. Lamas, Sexually acquired Zika virus: a systematic review, Clin. Microbiol. Infect, vol.23, pp.296-305, 2017.

A. A. Van-der-eijk, P. J. Van-genderen, R. M. Verdijk, C. B. Reusken, R. Mögling et al., Miscarriage associated with Zika virus infection, N. Engl. J. Med, vol.375, pp.1002-1004, 2016.

J. Mlakar, M. Korva, N. Tul, M. Popovi-c, M. Polj-sak-prijatelj et al., Zika virus associated with microcephaly, N. Engl. J. Med, vol.374, pp.951-958, 2016.

L. S. Muñoz, B. Parra, and C. A. Pardo, Neurological Implications of Zika Virus Infection in Adults, Neuroviruses Emerging in the Americas Study, vol.216, pp.897-905, 2017.

K. A. Dowd, S. Ko, K. M. Morabito, E. S. Yang, R. S. Pelc et al., Rapid development of a DNA vaccine for Zika virus, Science, vol.354, pp.237-240, 2016.

R. A. Larocca, P. Abbink, J. P. Peron, P. M. Zanotto, M. J. Iampietro et al., Vaccine protection against Zika virus from Brazil, Nature, vol.536, pp.474-478, 2016.

J. Zou, X. Xie, H. Luo, C. Shan, A. E. Muruato et al., A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity, EBioMedicine, vol.36, pp.92-102, 2018.

N. Pardi, M. J. Hogan, R. S. Pelc, H. Muramatsu, H. Andersen et al., Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination, Nature, vol.543, pp.248-251, 2017.

J. M. Richner, S. Himansu, K. A. Dowd, S. L. Butler, V. Salazar et al., Modified mRNA vaccines protect against Zika virus infection, Cell, vol.168, pp.1114-1125, 2017.

B. Dai, L. Yang, H. Yang, B. Hu, D. Baltimore et al., HIV-1 Gagspecific immunity induced by a lentivector-based vaccine directed to dendritic cells, Proc. Natl. Acad. Sci. USA, vol.106, pp.20382-20387, 2009.

C. Esslinger, L. Chapatte, D. Finke, I. Miconnet, P. Guillaume et al., In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8 + T cell responses, J. Clin. Invest, vol.111, pp.1673-1681, 2003.

K. Furmanov, M. Elnekave, D. Lehmann, B. E. Clausen, D. N. Kotton et al., The role of skin-derived dendritic cells in CD8 + T cell priming following immunization with lentivectors, J. Immunol, vol.184, pp.4889-4897, 2010.

S. Ciré, S. Da-rocha, R. Yao, S. Fisson, C. J. Buchholz et al., Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo, PLoS ONE, vol.9, 2014.

J. T. Kim, Y. Liu, R. P. Kulkarni, K. K. Lee, B. Dai et al., Dendritic cell-targeted lentiviral vector immunization uses pseudotransduction and DNA-mediated STING and cGAS activation, Sci. Immunol, vol.2, p.1329, 2017.

A. Follenzi, L. Santambrogio, A. , and A. , Immune responses to lentiviral vectors, Curr. Gene Ther, vol.7, pp.306-315, 2007.

F. X. Heinz, Epitope mapping of flavivirus glycoproteins, Adv. Virus Res, vol.31, pp.103-168, 1986.

M. De-wispelaere, M. Ricklin, P. Souque, M. P. Frenkiel, S. Paulous et al., A lentiviral vector expressing Japanese encephalitis virus-like particles elicits broad neutralizing antibody response in pigs, PLoS Negl. Trop. Dis, vol.9, p.4081, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01212231

T. Wang, J. F. Anderson, L. A. Magnarelli, S. J. Wong, R. A. Koski et al., Immunization of mice against West Nile virus with recombinant envelope protein, J. Immunol, vol.167, pp.5273-5277, 2001.

B. S. Davis, G. J. Chang, B. Cropp, J. T. Roehrig, D. A. Martin et al., West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays, J. Virol, vol.75, pp.4040-4047, 2001.

E. Frumence, W. Viranaicken, S. Bos, M. Alvarez-martinez, M. Roche et al., A chimeric Zika virus between viral strains MR766 and BeH819015 highlights a role for E-glycan loop in antibody-mediated virus neutralization. Vaccines (Basel) 7, p.55, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02477822

S. Philippe, C. Sarkis, M. Barkats, H. Mammeri, C. Ladroue et al., Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo, Proc. Natl. Acad. Sci. USA, vol.103, pp.17684-17689, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00166677

F. Coutant, R. Y. Sanchez-david, T. Félix, A. Boulay, L. Caleechurn et al., A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria, PLoS ONE, vol.7, p.48644, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-00764882

H. M. Lazear, J. Govero, A. M. Smith, D. J. Platt, E. Fernandez et al., A mouse model of Zika virus pathogenesis, Cell Host Microbe, vol.19, pp.720-730, 2016.

S. D. Dowall, V. A. Graham, E. Rayner, B. Atkinson, G. Hall et al., A susceptible mouse model for Zika virus infection, PLoS Negl. Trop. Dis, vol.10, p.4658, 2016.

N. K. Duggal, J. M. Ritter, S. E. Pestorius, S. R. Zaki, B. S. Davis et al., Frequent Zika virus sexual transmission and prolonged viral RNA shedding in an immunodeficient mouse model, Cell Rep, vol.18, pp.1751-1760, 2017.

B. Atkinson, F. Thorburn, C. Petridou, D. Bailey, R. Hewson et al., Presence and persistence of Zika virus RNA in semen, Emerg. Infect. Dis, vol.23, pp.611-615, 2016.

J. Emanuel, J. Callison, K. A. Dowd, T. C. Pierson, H. Feldmann et al., A VSV-based Zika virus vaccine protects mice from lethal challenge, Sci. Rep, vol.8, p.11043, 2018.

P. Abbink, R. A. Larocca, K. Visitsunthorn, M. Boyd, . De-la et al., , 2017.

, Durability and correlates of vaccine protection against Zika virus in rhesus monkeys, Sci. Transl. Med, vol.9, p.4163

F. Cox, L. Van-der-fits, P. Abbink, R. A. Larocca, E. Van-huizen et al., Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge, PLoS ONE, vol.13, 2018.

A. O. Hassan, I. P. Dmitriev, E. A. Kashentseva, H. Zhao, D. E. Brough et al., A gorilla adenovirus-based vaccine against Zika virus induces durable immunity and confers protection in pregnancy, Cell Rep, vol.28, pp.2634-2646, 2019.

H. N. Eisen and G. W. Siskind, Variations in affinities of antibodies during the immune response, Biochemistry, vol.3, pp.996-1008, 1964.

D. Bernstein, Glycoprotein D adjuvant herpes simplex virus vaccine, Expert Rev. Vaccines, vol.4, pp.615-627, 2005.

L. Corey, A. G. Langenberg, R. Ashley, R. E. Sekulovich, A. E. Izu et al., Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials, Chiron HSV Vaccine Study Group, vol.282, pp.331-340, 1999.

L. R. Stanberry, S. L. Spruance, A. L. Cunningham, D. I. Bernstein, A. Mindel et al., Glycoprotein-D-adjuvant vaccine to prevent genital herpes, GlaxoSmithKline Herpes Vaccine Efficacy Study Group, vol.347, pp.1652-1661, 2002.

S. L. Klein, A. Jedlicka, and A. Pekosz, The Xs and Y of immune responses to viral vaccines, Lancet Infect. Dis, vol.10, pp.338-349, 2010.

I. Zivkovi-c, B. Bufan, V. Petru-si-c, R. Mini-c, N. Arsenovi-c-ranin et al., Sexual diergism in antibody response to whole virus trivalent inactivated influenza vaccine in outbred mice, Vaccine, vol.33, pp.5546-5552, 2015.

A. L. Fink, K. Engle, R. L. Ursin, W. Y. Tang, and S. L. Klein, Biological sex affects vaccine efficacy and protection against influenza in mice, Proc. Natl. Acad. Sci. USA, vol.115, pp.12477-12482, 2018.

L. Stassen, C. W. Armitage, D. J. Van-der-heide, K. W. Beagley, and F. D. Frentiu, Zika virus in the male reproductive tract, Viruses, vol.10, 0198.

M. Arsuaga, S. G. Bujalance, M. Díaz-menéndez, A. Vázquez, and J. R. Arribas, Probable sexual transmission of Zika virus from a vasectomised man, Lancet Infect. Dis, vol.16, p.1107, 2016.

K. Stettler, M. Beltramello, D. A. Espinosa, V. Graham, A. Cassotta et al., Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection, Science, vol.353, pp.823-826, 2016.

G. Barba-spaeth, W. Dejnirattisai, A. Rouvinski, M. Vaney, I. Medits et al., Structural basis of potent Zika-dengue virus antibody cross-neutralization, Nature, vol.536, pp.48-53, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01408100

M. Beltramello, K. L. Williams, C. P. Simmons, A. Macagno, L. Simonelli et al., The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity, Cell Host Microbe, vol.8, pp.271-283, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00530282

W. Dejnirattisai, A. Jumnainsong, N. Onsirisakul, P. Fitton, S. Vasanawathana et al., Cross-reacting antibodies enhance dengue virus infection in humans, Science, vol.328, pp.745-748, 2010.

T. Langerak, N. Mumtaz, V. I. Tolk, E. C. Van-gorp, B. E. Martina et al., The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis, PLoS Pathog, vol.15, p.1007640, 2019.

M. A. Martín-acebes, J. C. Saiz, J. De-oya, and N. , Antibody-dependent enhancement and Zika: real threat or phantom menace? Front, Cell. Infect. Microbiol, vol.8, p.44, 2018.

R. A. Larocca, E. A. Mendes, P. Abbink, R. L. Peterson, A. J. Martinot et al., Adenovirus vector-based vaccines confer maternal-fetal protection against Zika virus challenge in pregnant IFN-abR À/À mice, Cell Host Microbe, vol.26, pp.591-600, 2019.

D. A. Benson, I. Karsch-mizrachi, D. J. Lipman, J. Ostell, and D. L. Wheeler, , 2007.

. Genbank, Nucleic Acids Res, vol.35, pp.21-25

F. Corpet, Multiple sequence alignment with hierarchical clustering, Nucleic Acids Res, vol.16, pp.10881-10890, 1988.
URL : https://hal.archives-ouvertes.fr/hal-02728178

V. Zennou, C. Petit, D. Guetard, U. Nerhbass, L. Montagnier et al., HIV-1 genome nuclear import is mediated by a central DNA flap, Cell, vol.101, pp.173-185, 2000.

M. C. Iglesias, M. Frenkiel, K. Mollier, P. Souque, P. Despres et al., A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus, J. Gene Med, vol.8, pp.265-274, 2006.

O. Faye, O. Faye, D. Diallo, M. Diallo, M. Weidmann et al., Quantitative real-time PCR detection of Zika virus and evaluation with field-caught mosquitoes, Virol. J, vol.10, p.311, 2013.

R. S. Lanciotti, O. L. Kosoy, J. J. Laven, J. O. Velez, A. J. Lambert et al., Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, Emerg. Infect. Dis, vol.14, pp.1232-1239, 2007.

L. J. Reed and H. Muench, A simple method of estimating fifty percent endpoints, Am. J. Epidemiol, vol.27, pp.493-497, 1938.

, www.moleculartherapy.org Molecular Therapy, vol.28, issue.8, 2020.